Asia-Pacific indapamide market is estimated to grow significantly at a CAGR of around 3.8% during the forecast period owing to the increasing prevalence of chronic disorders, including hypertension, CVD, and diabetes. The rising incidences of these diseases have been reported in several countries of Asia-Pacific, including China, India, and Singapore. For instance, in India, one in five young adults has high blood pressure, according to the data presented at the 70th Annual Conference of the Cardiological Society of India (CSI) held from November 22nd- 25th 2018. This equals to nearly 80 million adults, which is a significant proportion than the entire UK population. The risk factors for high blood pressure in the country were smoking, tobacco chewing, diabetes mellitus, and high cholesterol. This, in turn, increased the need for hypertension treatment in the region and further encourages the market growth.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/asia-pacific-indapamide-market

The market study of the Asia-Pacific indapamide market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.





Secondary Sources Include:

· Financial reports of companies involved in the market

· Whitepapers research-papers, and news blogs

· Company websites and their product catalogue



The report is intended for a healthcare service provider, medical device companies, government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.



A Full Report of Asia-Pacific Indapamide Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-indapamide-market





Market Overview and Insights

l Scope of the Report

l Analyst Insight & Current Market Trends

l Key Findings

l Recommendations

l Conclusion

l Rules & Regulations



Market Determinants

l Motivators

l Restraints

l Opportunities

Market Segmentation

l Asia-Pacific Indapamide Market by Product

l 1.25 MG

l 2.5 MG

l Asia-Pacific Indapamide Market by Application

l High Blood Pressure

l Heart Failure

l Others





Company Profiles



l ANI Pharmaceuticals, Inc.

l Glenmark Pharmaceuticals Ltd.

l Merck KGaA

l Sandoz International GmbH

l Sanofi S.A.

l Shandong Yinfeida Pharmaceutical Co., Ltd.

l Supra Chemicals

l Suzhou Lixin Pharmaceutical Co., Ltd.

l Taj Pharmaceuticals Ltd.

l Torrent Pharmaceuticals Ltd.



Regional Analysis

North America

l United States

l Canada

Europe

l UK

l Germany

l Italy

l Spain

l France

l Rest of Europe

Asia-Pacific

l China

l India

l Japan

l Rest of Asia-Pacific

l Rest of the World





For More Customized Data, Request for Report Customization @

https://www.omrglobal.com/report-customization/asia-pacific-indapamide-market



About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404